Xiaonan Shen

498 total citations
19 papers, 320 citations indexed

About

Xiaonan Shen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaonan Shen has authored 19 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaonan Shen's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xiaonan Shen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xiaonan Shen collaborates with scholars based in China, United States and Australia. Xiaonan Shen's co-authors include Xi Cheng, Haoran Feng, Ren Zhao, Weihua Qiu, Zhijian Jin, Juyong Liang, Xiaopin Ji, Jie Kuang, Yaqi Zhang and Haoxuan Wu and has published in prestigious journals such as International Journal of Cancer, Energy and Frontiers in Immunology.

In The Last Decade

Xiaonan Shen

18 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaonan Shen China 9 156 110 77 69 65 19 320
Zhehui Zhu China 8 165 1.1× 86 0.8× 54 0.7× 54 0.8× 34 0.5× 18 332
Jinglue Song China 10 243 1.6× 97 0.9× 54 0.7× 95 1.4× 38 0.6× 16 411
Haoxuan Wu China 13 213 1.4× 122 1.1× 62 0.8× 115 1.7× 101 1.6× 29 438
Jiunn-Chang Lin Taiwan 11 150 1.0× 152 1.4× 60 0.8× 79 1.1× 84 1.3× 27 426
Changku Jia China 10 238 1.5× 115 1.0× 73 0.9× 91 1.3× 55 0.8× 22 427
Judit López‐Luque Spain 8 179 1.1× 95 0.9× 37 0.5× 70 1.0× 56 0.9× 8 368
Jiuliang Yan China 11 133 0.9× 139 1.3× 45 0.6× 95 1.4× 73 1.1× 18 351
Yuqiang Shan China 9 178 1.1× 81 0.7× 66 0.9× 112 1.6× 82 1.3× 30 359
Hanzhang Zhu China 11 180 1.2× 103 0.9× 60 0.8× 115 1.7× 78 1.2× 18 377
Hong Yuan China 9 207 1.3× 121 1.1× 87 1.1× 118 1.7× 82 1.3× 36 454

Countries citing papers authored by Xiaonan Shen

Since Specialization
Citations

This map shows the geographic impact of Xiaonan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Shen more than expected).

Fields of papers citing papers by Xiaonan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaonan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Shen. The network helps show where Xiaonan Shen may publish in the future.

Co-authorship network of co-authors of Xiaonan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonan Shen. A scholar is included among the top collaborators of Xiaonan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonan Shen. Xiaonan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Shen, Xiaonan, et al.. (2024). Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing. Cancer Letters. 597. 217062–217062. 8 indexed citations
3.
Li, Haosheng, Xiaonan Shen, Kuai Liu, et al.. (2024). A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma. Acta Biomaterialia. 177. 456–471. 7 indexed citations
4.
Li, Haosheng, Haoran Feng, Tao Zhang, et al.. (2024). CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib. Molecular Cancer. 23(1). 59–59. 14 indexed citations
5.
Jia, Wenqing, Xiaonan Shen, Zichao Guo, Xi Cheng, & Ren Zhao. (2024). The future of cancer vaccines against colorectal cancer. Expert Opinion on Biological Therapy. 24(4). 269–284. 8 indexed citations
6.
Wang, Kui, Hong Yu, Jiawei Wang, et al.. (2023). Causal link between gut microbiota and four types of pancreatitis: a genetic association and bidirectional Mendelian randomization study. Frontiers in Microbiology. 14. 1290202–1290202. 17 indexed citations
7.
Zou, Duowu, Jie Zhong, Wei Wu, et al.. (2023). Convolutional neural network-based segmentation network applied to image recognition of angiodysplasias lesion under capsule endoscopy. World Journal of Gastroenterology. 29(5). 879–889. 14 indexed citations
8.
Li, Haosheng, Zichao Guo, Wenqing Jia, et al.. (2023). Identification and verification of a prognostic signature based on a miRNA–mRNA interaction pattern in colon adenocarcinoma. Frontiers in Cell and Developmental Biology. 11. 1161667–1161667. 1 indexed citations
9.
Chen, Yu, et al.. (2023). Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine. Biomedicine & Pharmacotherapy. 170. 115952–115952. 15 indexed citations
10.
Shen, Xiaonan, Chunhua Zhou, Haoran Feng, et al.. (2022). ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. Frontiers in Immunology. 13. 939806–939806. 6 indexed citations
11.
Zhang, Tao, Yaqi Zhang, Xiaonan Shen, et al.. (2021). LongTerm Outcomes of Three-Port Laparoscopic Right Hemicolectomy Versus Five-Port Laparoscopic Right Hemicolectomy: A Retrospective Study. Frontiers in Oncology. 11. 762716–762716. 3 indexed citations
12.
13.
Zhu, Kun, Chenfeng He, Siqi Liu, et al.. (2020). Lineage Tracking the Generation of T Regulatory Cells From Microbial Activated T Effector Cells in Naïve Mice. Frontiers in Immunology. 10. 3109–3109. 5 indexed citations
14.
Feng, Haoran, Xiaonan Shen, Juyong Liang, et al.. (2020). Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer. Cell Death and Disease. 11(10). 1006–1006. 40 indexed citations
15.
Feng, Haoran, Kun Liu, Xiaonan Shen, et al.. (2020). Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer. Cell Death and Disease. 11(11). 4 indexed citations
16.
Shen, Xiaonan, Yao Zhang, Xiaobo Li, et al.. (2020). The Coexistence of Colorectal Polyps in the Right Colon Increases the Malignant Risk of Laterally Spreading Tumors. Gastroenterology Research and Practice. 2020. 1–8. 1 indexed citations
17.
Cheng, Xi, Zhijian Jin, Xiaopin Ji, et al.. (2019). ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BB. International Journal of Cancer. 145(1). 179–191. 30 indexed citations
18.
Cheng, Xi, Jie Kuang, Haoran Feng, et al.. (2018). CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species. Molecular Oncology. 12(4). 529–544. 38 indexed citations
19.
Cheng, Xi, Haoran Feng, Haoxuan Wu, et al.. (2018). Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer. Cancer Letters. 431. 105–114. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026